Patents by Inventor Robin L. Davisson

Robin L. Davisson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10093947
    Abstract: The invention is directed to an adeno-associated virus (AAV) vector which comprises a nucleic acid sequence encoding an antibody or antigen binding fragment that binds to nicotine or a nicotine analog. The invention also is directed to a composition comprising the AAV vector and methods of using the AAV vector to induce an immune response against nicotine in a mammal.
    Type: Grant
    Filed: February 25, 2013
    Date of Patent: October 9, 2018
    Assignee: CORNELL UNIVERSITY
    Inventors: Ronald G. Crystal, Martin J. Hicks, Jonathan B. Rosenberg, Bishnu P. De, Stephen M. Kaminsky, Robin L. Davisson
  • Publication number: 20150056251
    Abstract: The invention is directed to an adeno-associated virus (AAV) vector which comprises a nucleic acid sequence encoding an antibody that binds to nicotine or a nicotine analog, or an antigen-binding fragment thereof. The invention also is directed to a composition comprising the AAV vector and methods of using the AAV vector to induce an immune response against nicotine in a mammal.
    Type: Application
    Filed: February 25, 2013
    Publication date: February 26, 2015
    Inventors: Ronald G. Crystal, Martin J. Hicks, Jonathan B. Rosenberg, Bishnu P. De, Stephen M. Kaminsky, Robin L. Davisson
  • Patent number: 7045674
    Abstract: The invention provides an animal model for preeclampsia that allows candidate compounds to be screened for their ability to treat preeclampsia.
    Type: Grant
    Filed: September 19, 2003
    Date of Patent: May 16, 2006
    Assignee: University of Iowa Research Foundation
    Inventor: Robin L. Davisson
  • Publication number: 20040133929
    Abstract: The invention provides an animal model for preeclampsia that allows candidate compounds to be screened for their ability to treat preeclampsia.
    Type: Application
    Filed: September 19, 2003
    Publication date: July 8, 2004
    Inventor: Robin L. Davisson